MUNDIPHARMA INTERNATIONAL LIMITED
Company Information
- Company Number
- 02763367
- Registered Address
- Unit 191 Cambridge Science Park, Milton Road, Cambridge, United Kingdom, CB4 0GW
- Status
- Active
- Employee Count
- 77
- Turnover
- £28,323,000
- EBITDA
- £2,263,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 9 November 1992
- Nature of Business
- 70229 - Management consultancy activities other than financial management
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Company Review
Trend Analysis
MUNDIPHARMA INTERNATIONAL LIMITED exhibits a consistent trend of extended payment cycles, with an average payment time of 118 days. A substantial 65% of payments are made after 30 days, including 25% extending beyond 60 days, indicating a deliberate and consistently slow payment speed rather than rapid fluctuations.
Volatility Analysis
The payment data suggests a predictable slowness rather than high unpredictability, as the majority of payments consistently fall into longer timeframes. While only 7% are formally 'late', the high average payment time of 118 days points to a reliable pattern of delayed disbursements, posing a consistent cash flow strain rather than sporadic volatility.
Summary Analysis
Suppliers should anticipate significantly extended payment terms when dealing with MUNDIPHARMA INTERNATIONAL LIMITED, requiring robust working capital management. Key decision factors include the supplier's capacity to absorb long payment cycles; consider negotiating shorter payment terms or adjusting pricing to account for the average 118-day cycle to mitigate cash flow risks.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2024 - 31 Dec 2024 | 19 Feb 2025 | 69 | 54% | 31% | 15% | 47% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The default position is 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
If suppliers have a query or dispute relating to a payment they believe is owed to them by MINT, they will need to email the following details below, to MINT.APQueries@mundipharma.com a. Full supplier name, address. b. The name of your MINT point of contact. c. Invoice number for the payment you are querying. d. Full details of your complaint. Upon receipt of all the above details, MINT commits to acknowledge receipt of your email within five working days and may request further information to be able to respond in full. MINT will investigate your query using the details provided and speak with relevant members of MINT’s business, including members of MINT’s legal department if necessary, and respond in full within 14 days of the date of MINT’s acknowledgement to you.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
MUNDIPHARMA INTERNATIONAL LIMITED is an active private limited company operating within the pharmaceutical sector. Its name indicates an international focus within the pharmaceutical industry.
The company was incorporated on 9 November 1992 and holds the company number 02763367. Its registered office is located at Unit 191 Cambridge Science Park, Milton Road, Cambridge, United Kingdom, CB4 0GW, placing its operations within the East of England.
As a private limited company in the pharmaceutical sector, such organisations typically engage in the research, development, manufacture, and distribution of pharmaceutical products. They often specialise in bringing new medicines to market and managing their supply chains within both domestic and international healthcare markets.
